Irl B. Hirsch, MD

Articles by Irl B. Hirsch, MD

HEDIS Glycemic Goal Achieved Using Control-IQ Technology

ByBimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Miranda R. Polin, MS, BS,Irl B. Hirsch, MD,Laya Ekhlaspour, MD,Steve Edelman, MD,Diana I. Brixner, PhD, RPh,Charles Stemple, DO

December 22nd 2025

A greater proportion of patients with type 1 diabetes who used automated insulin delivery systems vs multiple daily injections achieved the Healthcare Effectiveness Data and Information Set (HEDIS) glycemic measure.

The Role of Advanced Technologies in Improving Diabetes Outcomes

ByDavid G. Marrero, PhD,Christopher G. Parkin, MS,Grazia Aleppo, MD,Irl B. Hirsch, MD,Janet McGill, MD, MA,Rodolfo J. Galindo, MD,Davida F. Kruger, MSN, APRN-BC, BC-ADM,Carol J. Levy, MD, CDE,Anders L. Carlson, MD,Guillermo E. Umpierrez, MD, CDE

April 7th 2025

This article reviews underlying barriers to health care access and discusses how a value-based diabetes care model could improve patient outcomes and reduce long-term costs.

Latest Updated Articles

HEDIS Glycemic Goal Achieved Using Control-IQ Technology
December 22nd 2025
The Role of Advanced Technologies in Improving Diabetes Outcomes
April 7th 2025

Irl B. Hirsch, MD

Articles by Irl B. Hirsch, MD

HEDIS Glycemic Goal Achieved Using Control-IQ Technology

The Role of Advanced Technologies in Improving Diabetes Outcomes

Latest Updated Articles

Trending on AJMC

FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs

Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV

Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD

Study Finds Flaw in Method for Key Oncology Value-Based Care Model

Ontada Analysis Finds GLP-1 RA Use Linked to Improved Survival in Patients With Cancer